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Background Following the outbreaks of 2009 pandemic H1N1
infection, rapid influenza diagnostic tests have been used to detect
H1N1 infection. However, no meta-analysis has been undertaken
to assess the diagnostic accuracy when this manuscript was
drafted.
Methods The literature was systematically searched to identify
studies that reported the performance of rapid tests. Random
effects meta-analyses were conducted to summarize the overall
performance.
Results Seventeen studies were selected with 1879 cases and 3477
non-cases. The overall sensitivity and specificity estimates of the
rapid tests were 0Æ51 (95%CI: 0Æ41, 0Æ60) and 0Æ98 (95%CI: 0Æ94,
0Æ99). Studies reported heterogeneous sensitivity estimates, ranging
from 0Æ11 to 0Æ88. If the prevalence was 30%, the overall positive
and negative predictive values were 0Æ94 (95%CI: 0Æ85, 0Æ98) and
0Æ82 (95%CI: 0Æ79, 0Æ85). The overall specificities from different
manufacturers were comparable, while there were some differences
for the overall sensitivity estimates. BinaxNOW had a lower
overall sensitivity of 0Æ39 (95%CI: 0Æ24, 0Æ57) compared with all
the others (P-value <0Æ001), whereas QuickVue had a higher
overall sensitivity of 0Æ57 (95%CI: 0Æ50, 0Æ63) compared with all
the others (P-value = 0Æ005).
Conclusions Rapid tests have high specificity but low sensitivity
and thus limited usefulness.
Keywords Diagnostic tests, H1N1, meta-analysis, rapid tests,
sensitivity and specificity.
Please cite this paper as: Chu et al (2012) Performance of rapid influenza H1N1 diagnostic tests: a meta-analysis. Influenza and Other Respiratory Viruses
6(2), 80–86.
Introduction
Real-time reverse-transcriptase polymerase chain reaction
(rRT-PCR) is the most accurate method in detecting influ-
enza A (H1N1) virus infection in respiratory specimens.
However, the facilities and expertise for performing rRT-
PCR are not uniformly available, and the results from rRT-
PCR are generally not immediately accessible, which poses
challenges in establishing a diagnosis, especially in patients
presenting late in their clinical course.1 Rapid influenza
diagnostic tests (henceforth, rapid tests) that detect influ-
enza viral antigens produce quick results that can be used
to screen patients with suspected influenza. Although as
the 2009 pandemic H1N1 progressed, some new rapid tests
were developed, the rapid tests used in the majority of
studies were already in use and not developed specifically
to detect H1N1. Specifically, during the beginning of the
pandemic, their performance for the detection of 2009 pan-
demic H1N1 was not known. The lack of specific rapid
and accurate diagnostics for H1N1 has been a major con-
cern for monitoring and controlling outbreaks of 2009 pan-
demic influenza A (H1N1) infection. When they were
developed, rapid influenza diagnostic tests were introduced
as promising novel approach to detect this virus. Several
commercial antigen assays, although not specifically
designed for diagnosing 2009 pandemic H1N1, were
quickly introduced to the market. However, rapid test per-
formance has been less than optimal.1 Compared to rRT-
PCR, several previous studies reported consistently high
specificity but inconsistent estimates of sensitivity using
rapid tests to detect 2009 H1N1 virus infection in upper
respiratory specimens.2,3 When this manuscript was
drafted, no meta-analysis of the diagnostic accuracy of
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although Babin et al4 published a meta-analysis recently.
Here, we use a comprehensive search strategy and meta-
analytic methods to determine the accuracy of existing
rapid tests for diagnosing 2009 H1N1 virus infection.
Methods
Findings are reported according to the Quality of Reporting
of Meta-Analysis (QUOROM) statement5 and the Standards
for Reporting of Diagnostic Accuracy (STARD) statement.6
Search strategy
The literature was systematically searched using predeter-
mined inclusion criteria. Studies were included that
reported the sensitivity and ⁄ or specificity of an influenza
rapid test to detect the presence of 2009 pandemic influ-
enza (H1N1) infection or contained sufficient information
to calculate the sensitivity and specificity based on diagno-
sis of clinical specimens using the rRT-PCR as a gold stan-
dard reference test. No language restrictions were applied.
Studies were identified eligible for inclusion by searching
the databases MEDLINE (NLOM, Bethesda, MD, USA)
and EMBASE (Elsevier, Amsterdam, the Netherlands) using
PUBMED and OVID interfaces, respectively. Publication
dates were restricted to between 1 ⁄ 1 ⁄ 2009 and 1 ⁄ 15 ⁄ 2010,
inclusive. Search terms for each database included the fol-
lowing: ‘‘influenza diagnostic,’’ ‘‘influenza rapid test,’’
‘‘rapid test H1N1,’’ and ‘‘influenza rapid’’. Subsequently,
the title and abstract of each potential study were screened
to determine potential eligibility, which was then confirmed
by a review of the full text. References from eligible studies
were also examined for additional potential studies, and
papers referencing eligible studies were identified using
Google Scholar and considered for inclusion.
Data synthesis and meta-analysis
Data synthesis was performed according to guidelines on
systematic reviews of diagnostic accuracy studies.7,8 The
bivariate logit-normal random effects meta-analyses were
conducted to summarize the overall sensitivity and specific-
ity of rapid tests.9–14 Compared to fixed effects models, the
random effects models typically provide conservative esti-
mates with wider confidence intervals because it assumes
that the meta-analysis includes only a sample of all possible
studies. In addition, the random effects models appropri-
ately account for the difference in study sample sizes, both
within-study variability (random error) and between-study
variability (heterogeneity).15,16 In general, the bivariate
approach offers some advantages over separate univariate
random effects meta-analysis by accounting for the correla-
tion between sensitivity and specificity.17–19 This correlation
will exist if the different studies use different test-thresholds
and thus are operating at different points along the under-
lying receiver operating characteristic (ROC) curve for the
test. However, one study reported that the differences
between univariate and bivariate random effects models for
summarizing pooled sensitivity and specificity are trivial
based on extensive simulations.20 Thus, we utilized the uni-
variate logit-normal random effects meta-analyses to gener-
ate forest plots (i.e., graphical display designed to illustrate
the relative strength in meta-analysis of multiple quantita-
tive scientific studies addressing the same question) with
overall and rapid test-specific pooled estimates for both
sensitivity and specificity. Parameters used to summarize
diagnostic accuracy include the following: sensitivity and
specificity directly estimated from the univariate and ⁄ or
bivariate random effects models; positive and negative like-
lihood ratio, positive and negative predictive values, and
the diagnostic odds ratio (DOR) derived from parameter
estimates from the bivariate random effects models
accounting for potential correlation between sensitivity and
specificity estimates. In addition to reporting pooled sensi-
tivity and specificity, which are often regarded as intrinsic
properties of a diagnostic test, we also report other metrics
because they are clinically more meaningful in some set-
tings. Sensitivity is estimated by the proportion of positive
tests among those with the disease of interest, whereas
specificity is estimated by the proportion of negative tests
among those without the disease. The positive (or negative)
likelihood ratio is estimated by the ratio of the proportion
of positive (or negative) tests in the diseased versus non-
diseased subjects. The positive (or negative) predictive
value is estimated by the proportion of subjects with a
positive (or negative) test who have (or do not have) the
disease. The DOR, commonly considered a global measure
of test performance, is estimated by the ratio of the odds
of a positive test result in diseased subjects to the odds of a
positive test result in non-diseased subjects.
The Begg- and Mazumdar-adjusted rank correlation
test21 and the Egger et al.22 regression asymmetry test were
used to assess publication bias for sensitivity and specificity,
respectively. The Cochran’s Q-test was used to detect heter-
ogeneity.23 Location (US versus non-US) and rapid test
manufacturer were included as covariates to examine their
possibility as factors causing heterogeneity. Tests for small-
study effects were employed only when at least four studies
were available. The univariate logit-normal random effects
meta-analyses were implemented in R version 2Æ12Æ1
(http://cran.r-project.org/) meta package,24,25 and the bivar-
iate random effects models were fitted using the NLMIXED
procedure in SAS version 9Æ2 (SAS Institute, Cary, NC,
USA). The summary ROC curve was plotted based on the
regression line of sensitivity on the false-positive rate
(1–Sp) in logit scale using the estimates from the bivariate
random effects models12 rather than the line proposed by
Rutter and Gatsonis.26,27
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Results
We identified 2054 citations from MEDLINE and 775 cita-
tions from EMBASE, with overlap from the initial search.
After screening titles and abstracts, 85 articles were eligible
for full-text review. Of these, 68 articles were excluded, and
17 articles 11 on the sensitivity (specificity) of rapid influ-
enza H1N1 diagnostic test were included, as presented in
Table 1. Three studies have contributed results for multiple
rapid tests28–30 producing a total of 22 sensitivity estimates
and 12 specificity estimates. Specifically, six (three) studies
reported sensitivity (specificity) estimates of BinaxNOW
Influenza A & B2,28–32; seven (four) studies reported sensi-
tivity (specificity) estimates of QuickVue Influenza
A + B28,30,33–37; four (two) studies reported sensitivity
(specificity) estimates of BD Directigen EZ Flu A + B
test28,30,38,39; two (one) studies reported sensitivity (speci-
ficity) estimates of Espline Influenza A & B29,40; and one
study reported sensitivity and specificity estimates of Xpect
Flu A & B.41 The seven (four) studies reporting sensitivity
(specificity) of BD Directigen, Espline, and Xpect were
grouped together because of small numbers of studies for
these tests. One study reported sensitivity and specificity
estimates of either BinaxNOW Influenza A & B test or the
3M Rapid Detection Flu A + B test,42 and one study
reported sensitivity estimate of either QuickVue Influenza
A + B or SD Bioline Influenza Antigen test. These two
studies are excluded for the analyses of pooled sensitivities
and specificities of QuickVue Influenza A + B test and Bi-
naxNOW Influenza A & B test as we cannot calculate the
number of false positives, true negatives, false negatives,
and true positives for either test. However, we included
them for the analyses of pooled overall sensitivity and spec-
ificity of rapid tests.
The average sample size of the included seventeen studies
was 315 (range 17–1831), with a total of 1879 cases and
3477 non-cases confirmed by rRT-PCR. The majority
(82% = 14 of 17) of the studies were prospective. The
Table 1. Study details of articles that reported (or with enough information to back calculate) the number of true positives (TP), false negatives





year Rapid tests Population Specimen type Prospective TP FN FP TN
1 Balish 08 ⁄ 2009 BinaxNOW Influenza A & B USA Nasopharyngeal samples Yes 18 27
QuickVue A + B 31 14
Directigen EZ Flu A + B 22 23
2 Blyth 11 ⁄ 2009 QuickVue A + B Australia Samples from nose and
throat
Yes 5 12
3 Brouqui 10 ⁄ 2009 Directigen EZ Flu A + B France Source unspecified Yes 19 12 2 270
4 Cheng 02 ⁄ 2010 Espline Influenza A & B Hong Kong Nasopharyngeal samples Yes 37 23
5 Drexler 10 ⁄ 2009 BinaxNOW Influenza A & B Germany Samples from nose and
throat
No 16 128
6 Faix 08 ⁄ 2009 QuickVue A + B CA, USA Source unspecified Yes 20 19 2 100
7 Fuenzalida 12 ⁄ 2009 BinaxNOW Influenza A & B Spain Nasopharyngeal samples Yes 137 90 18 267
8 Ginocchio 06 ⁄ 2009 BinaxNOW Influenza A & B or
3M Rapid Detection Flu A + B
NY, USA Nasopharyngeal samples Yes 26 97 9 1699
9 Karre 11 ⁄ 2009 Directigen EZ Flu A + B CO, USA Nasopharyngeal samples Yes 39 41 5 140
10 Kok 01 ⁄ 2010 QuickVue A + B Australia Samples from nose and
throat
Yes 93 81 0 326
11 Leveque 01 ⁄ 2010 BinaxNOW Influenza A & B France Nasal samples only No 9 16 0 5
Espline Influenza A & B 16 9 0 5
12 Likitnukul 11 ⁄ 2009 QuickVue A + B or SD Bioline
Influenza Antigen
Thailand Nasal samples only Yes 376 53
13 Sabetta 11 ⁄ 2009 Xpect Flu A & B CT, USA Nasopharyngeal samples Yes 23 26 2 12
14 Sandora 03 ⁄ 2010 BinaxNOW Influenza A & B MA, USA Nasopharyngeal samples Yes 124 84 1 332
15 Suntarattiwong 04 ⁄ 2010 QuickVue A + B Thailand Samples from nose and
throat
Yes 89 53 2 234
16 Vasoo* 10 ⁄ 2009 BinaxNOW Influenza A & B IL, USA Nasopharyngeal samples No 23 37
QuickVue A + B 32 28
Directigen EZ Flu A + B 28 32
17 Watcharananan 01 ⁄ 2010 QuickVue A + B Thailand Nasopharyngeal samples Yes 16 10 10 41
*Vasoo et al. incorrectly reported specificity for rapid tests on all confirmed positive specimens.
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overall sensitivity and specificity estimates were 0Æ51 (95%
CI: 0Æ41, 0Æ60; range 0Æ11–0Æ88) and 0Æ99 (95% CI: 0Æ94,
0Æ99; range 0Æ80–1Æ00) from the univariate random effects
models. Figures 1 and 2 show the diagnostic accuracy mea-
sures from all the studies, stratified by the rapid test manu-
facturer using the bivariate random effects models. Based
on the Q statistics, both the sensitivity and specificity
showed highly significant between-study heterogeneity in
the summary results (P-value <0Æ001).
Specificity appeared to be more consistent than sensitiv-
ity from different manufacturers. The overall specificities
from different manufacturers were comparable as seen in
Figure 2. However, there were some differences for the
overall sensitivity estimates from different manufacturers.
BinaxNOW had a lower overall sensitivity (0Æ39 with
95%CI: 0Æ24, 0Æ57) compared with all the others (P-value
<0Æ001), whereas QuickVue had a higher overall sensitivity
(0Æ57 with 95%CI: 0Æ50, 0Æ63) compared with all the others
(P-value = 0Æ005) from the bivariate random effects model.
Begg’s adjusted rank correlation test (P-value = 0Æ40
and 0Æ53) showed no evidence of publication bias for both
sensitivity and specificity, whereas the Egger’s regression
asymmetry test (P-value = 0Æ07 and 0Æ06) suggested that
some publication bias may exist for both sensitivity and
specificity. Because we had a total of 22 sensitivity esti-
mates but only had 12 specificity estimates, we did not
consider the modified Begg- and Mazumdar-adjusted rank
correlation test and the modified Egger et al. regression
asymmetry test to detect the publication bias in log DOR
scale, which has been shown to perform slightly better by
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Figure 1. Forest plot of sensitivity estimates and 95% confidence intervals (CI). Point estimates of sensitivity from each study are shown as solid
squares. Solid lines represent the 95% CIs. Squares are proportional to weights based on the random effects model. The pooled estimate and 95%
CI is denoted by the diamond at the bottom. Se, sensitivity; TP, true positives; FN, false negatives.
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Based on the bivariate logit-normal random effects mod-
els, the correlation between sensitivity and specificity was
only 0Æ32 (95%CI )0Æ64, 0Æ89) on the logit scale, suggesting
no evidence of strong correlation. The overall positive like-
lihood ratio was 34Æ5 (95% CI: 12Æ7, 93Æ6), and the overall
negative likelihood ratio was 0Æ48 (95%CI: 0Æ39, 0Æ60). The
DOR was 71Æ6 (95%CI: 26Æ3, 194Æ6). Study location (US
versus non-US) was not associated with sensitivity and
specificity (P-value = 0Æ41 and 0Æ86, respectively). Sampling
type (Nasopharyngeal samples versus the other) was not
associated with sensitivity (P-value = 0Æ95), but associated
with specificity (P-value = 0Æ03). Nasopharyngeal samples
have a specificity of 0Æ97 (95%CI: 0Æ90, 0Æ99), and the other
samples have a specificity of 1Æ00 (95%CI: 0Æ98, 1Æ00).
Figure 3A presents the 95% confidence region of the
summary point, the 95% prediction region and the sum-
mary receiver operating characteristic curve.44 The area
under the curve was 0Æ68 (95%CI: 0Æ20, 0Æ92). Figure 3B
shows the estimated positive and negative predictive values
with their point-wise 95% confidence intervals based on the
overall estimates of sensitivity and specificity. For example,
when the prevalence was 30%, the estimated overall positive
and negative predictive values were 0Æ94 (95%CI: 0Æ85, 0Æ98)
and 0Æ82 (95%CI: 0Æ79, 0Æ85), suggesting limited usefulness.
Discussion
An extensive literature search indentified 17 articles that
reported rapid test results from clinical specimens. Meta-
analysis results showed that the specificity estimates for
existing commercial rapid tests are high and relatively con-
sistent ranging from 0Æ80 to 1Æ00. However, the sensitivity
is low and highly variable ranging from 0Æ11 to 0Æ88. A lack
of sensitivity is of particular concern in the present setting.
Rapid tests are useful as a screening device to the extent
that they identify possible cases. Therefore, high sensitivity
is essential.
Rapid tests with improved performance are needed.
Alternatively, testing strategies that employ multiple rapid
tests may improve sensitivity. For example, use of two dif-
ferent rapid tests on sequential biologic samples of the
same individual may provide partially independent infor-
mation. If an individual is defined as positive when at least
one of the rapid tests is positive, the upper bound on
improved sensitivity is the complement of the probability
that both tests yield false-negative results. Using the overall
sensitivity estimates from QuickVue and other manufac-
tures, this would yield an possibly acceptable sensitivity of
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Figure 2. Forest plot of specificity estimates and 95% confidence intervals (CI). Point estimates of sensitivity from each study are shown as solid
squares. Solid lines represent the 95% CIs. Squares are proportional to weights based on the random effects model. The pooled estimate and 95%
CI is denoted by the diamond at the bottom. Sp, specificity; TN, true negatives; FP, false positives.
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dently. However, this strategy would double the cost of
testing and would also require the collection of a second
sample, delaying time to results.
In conclusion, real-time reverse-transcriptase polymerase
chain reaction remains the most accurate method for
detecting 2009 pandemic influenza A (H1N1) virus infec-
tion. Because rRT-PCR results are not immediately acces-
sible, and a laboratory with the necessary equipment and
required skill level to avoid common technical errors that
may occur with rRT-PCR may not be available, rapid
procedures with adequate diagnostic test characteristics
are needed, and existing rapid tests are inadequate. Alter-
native solutions to address poor test sensitivity are
needed.
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